Yeah good point, ALC isn't a Biotech, but you're incorrect about spending capital for revenue. It's organic growth has been quite decent and now also just hitting EBIT positive.
We should discuss this on the ALC thread
RAP Price at posting:
20.5¢ Sentiment: None Disclosure: Not Held